Mehul Suthar to Antibodies, Neutralizing
This is a "connection" page, showing publications Mehul Suthar has written about Antibodies, Neutralizing.
Connection Strength
0.818
-
Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination. JAMA. 2021 05 11; 325(18):1896-1898.
Score: 0.133
-
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant. Cell Host Microbe. 2021 04 14; 29(4):516-521.e3.
Score: 0.131
-
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Curr Protoc Immunol. 2020 12; 131(1):e116.
Score: 0.129
-
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection. PLoS One. 2021; 16(8):e0256482.
Score: 0.034
-
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021 09 17; 373(6561):1372-1377.
Score: 0.034
-
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep. 2021 07 27; 36(4):109452.
Score: 0.034
-
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants. N Engl J Med. 2021 08 12; 385(7):664-666.
Score: 0.034
-
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021 07 13; 36(2):109353.
Score: 0.033
-
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 06; 594(7862):253-258.
Score: 0.033
-
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India. Virology. 2021 06; 558:13-21.
Score: 0.033
-
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med. 2021 01 07; 384(1):80-82.
Score: 0.032
-
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat Commun. 2020 10 27; 11(1):5413.
Score: 0.032
-
Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages. Cell Host Microbe. 2018 11 14; 24(5):731-742.e6.
Score: 0.028
-
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates. Nat Immunol. 2021 10; 22(10):1306-1315.
Score: 0.008
-
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med. 2021 08 18; 13(607).
Score: 0.008
-
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Sci Immunol. 2021 07 15; 6(61).
Score: 0.008
-
Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021 08; 596(7872):410-416.
Score: 0.008
-
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
Score: 0.008
-
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nat Commun. 2021 06 11; 12(1):3587.
Score: 0.008
-
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N Engl J Med. 2021 06 10; 384(23):2259-2261.
Score: 0.008
-
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. 2021 03 09; 54(3):542-556.e9.
Score: 0.008
-
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
Score: 0.008
-
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med. 2020 12 17; 383(25):2427-2438.
Score: 0.008
-
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease. Blood Adv. 2020 09 22; 4(18):4278-4281.
Score: 0.008
-
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Pediatrics. 2020 12; 146(6).
Score: 0.008